Security: Series B Preferred & Debt

President & CEO: Richard Daly

New Investors: Marathon, Undisclosed
Existing Investors: Oxford Bioscience Partners, Chrysalis Ventures, Fort Washington Private Equity, Hillside Capital Management

Board of Directors: Jonathan Fleming, David Jones, Jack Davis, Richard Daly

- Closing of private placement concurrent with acquisition of regional clinical laboratory.

- Acquisition financing including debt and equity.